maxPro Male Extend
Natural health product licensed in Canada
- Other names
- Max Male Libido, Max Male Peak, Max Male Testosterone
- Licence holder
- Natural Equivalents Incorporated
- NPN or DIN-HM
- 80088596
- Status
- Active licence
- Licence date
- 4 October 2018
- Revision date
- 9 June 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 125 mg | 5 mg | Not calculated |
| Eurycoma longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 10,000 mg Potency : 40 % Glycosaponins | 100 mg | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 22 % Eurypeptides | Not specified | Not calculated |
| Ptychopetalum olacoides Source : Racine | 25 mg | Not calculated |
| Asparagus racemosus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl | 5 mg | Not calculated |
| Bore Source : Citrate de bore | 300 mcg | Not calculated |
| Sélénium Source : Sélénite de sodium | 100 mcg | 200 µg |
| L-arginine | 75 mg | Not calculated |
| Zinc Source : Citrate de zinc dihydraté | 25 mg | 50,000 µg |
| Turnera diffusa Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 250 mg | 12.5 mg | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 150 mg | 12.5 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Helps support healthy sexual interest. Eurycoma longifolia helps promote testosterone production. Eurycoma longifolia supports testosterone production. Source of/Provides antioxidants. Source of selenium, to support biological functions. Helps in connective tissue formation. Helps the body to metabolize carbohydrates, proteins and fats. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Zinc supplementation can cause a copper deficiency. If you are unsure whether you are taking enough copper, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you have prostate cancer, diabetes mellitus, heart, kidney or liver disease. Do not use if you have a known allergy or hypersensitivity to Eurycoma longifolia, its constituents, or members of the Simaroubaceae family.
- Précautions et mises en garde
If you have a history of non-melanoma skin cancer, consult a health care practitioner prior to use. Consult a health care practitioner, If symptoms persist or worsen. Consult a healthcare practitioner prior to use if you have a weakened immune system or have been diagnosed with hypoactive sexual disorder, sexual dysfunction or erectile dysfunction or have high blood pressure or suffer from any psychological disorder and/or condition such as frequent anxiety or depression or taking hypoglycemic agents, anti-depressants, blood thinners, digoxin, propranolol or blood pressure medication.
Source
Official Health Canada record, licence 80088596
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging